Covered recipient · General Payments record
TEMITOPE J AJAGBE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$567.82
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $288.61 | 16 |
| Education | $8.90 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $169.96 | 12 |
| Abbott Laboratories | $65.64 | 3 |
| Acerta Pharma LLC | $61.91 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124915797 | CMS |
| Abbott Laboratories | $28.12 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124915799 | CMS |
| Abbott Laboratories | $20.92 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124915801 | CMS |
| AstraZeneca Pharmaceuticals LP | $28.14 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104537508 | CMS |
| AstraZeneca Pharmaceuticals LP | $33.77 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104341730 | CMS |
| Novo Nordisk Inc | $11.37 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096725777 | CMS |
| Novo Nordisk Inc | $21.49 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097698020 | CMS |
| Novo Nordisk Inc | $15.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096602741 | CMS |
| Novo Nordisk Inc | $18.25 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097748623 | CMS |
| Novo Nordisk Inc | $9.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097132827 | CMS |
| Novo Nordisk Inc | $8.90 | 05/08/2024 | Education | Undisputed | 01/23/2026 | 1097695124 | CMS |
| Novo Nordisk Inc | $23.52 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097527960 | CMS |
| Novo Nordisk Inc | $7.28 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096849004 | CMS |
| Novo Nordisk Inc | $9.65 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573426 | CMS |
| Novo Nordisk Inc | $24.97 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097737348 | CMS |
| Novo Nordisk Inc | $12.91 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097475535 | CMS |
| Novo Nordisk Inc | $7.05 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919876 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.